Pacira BioSciences market cap PCRX

Share price times shares outstanding: what the whole company sells for, since 2011.

Pacira BioSciences is worth $1.5B at the close on Oct 23, 2026, at $36.42 a share.

That is up 49% over the last year and down 38% over five years.

Its highest close in our data was $4.2B in Feb 2015.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$1.5B	$824.3M	$1.5B	+27%
2025	$1.1B	$849.6M	$1.2B	+26%
2024	$907.3M	$539.7M	$1.6B	−42%
2023	$1.6B	$1.2B	$2.2B	−12%
2022	$1.8B	$1.8B	$3.7B	−34%
2021	$2.7B	$2.1B	$3.3B	+3%
2020	$2.6B	$1.3B	$2.9B	+40%
2019	$1.9B	$1.5B	$2B	+6%
2018	$1.7B	$1.2B	$2.1B	−6%
2017	$1.9B	$1.3B	$2.1B	+53%
2016	$1.2B	$1.1B	$2.5B	−57%
2015	$2.8B	$1.5B	$4.2B	−16%
2014	$3.4B	$1.9B	$3.9B	+78%
2013	$1.9B	$583M	$1.9B	+234%
2012	$567.1M	$137.7M	$616.6M	+281%
2011	$149M	$123.2M	$182M	n/a

Companies in Drug Manufacturers - General nearest Pacira BioSciences' size, closest first, today.

Company	Market cap
PCRXPacira BioSciences	$1.5B
ANABAnaptysbio	$1.5B
PAHCPhibro Animal Health	$1.6B
ANIPANI Pharmaceuticals	$1.7B
OMEROmeros	$1.2B
AMPHAmphastar Pharmaceuticals	$1.1B
HRMYHarmony Biosciences	$2.1B
PBHPrestige Consumer Healthcare	$2.3B
ABUSArbutus Biopharma	$831M
NRIXNurix Therapeutics	$2.8B
COLLCollegium Pharmaceutical	$747.5M
Peer median	$1.5B